Welcome to CDC stacks | National Amyotrophic Lateral Sclerosis (ALS) Biorepository Governance : February 12, 2013 summary report - 27709 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
National Amyotrophic Lateral Sclerosis (ALS) Biorepository Governance : February 12, 2013 summary report
  • Published Date:
    2013
  • Language:
    English
Filetype[PDF-516.92 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. The National Amyotrophic Lateral Sclerosis (ALS) Registry first Biorepository pilot study expert panel meeting : March 26-27 summary report
    Corporate Author:
    United States. Agency for Toxic Substances and Disease Registry.
    Published:
    2012
    Description:
    This document has not been revised or edited to conform to agency standards. The findings and conclusions in this report are those of the meeting presenters and attendees and do not necessarily represent the views of the Agency for Toxic Substances a...
    File Type:
    Filetype[PDF - 1.01 MB]
  2. 2016 Annual ALS Surveillance Meeting executive summary, August 3-4, 2016
    Corporate Author:
    United States. Agency for Toxic Substances and Disease Registry.
    Description:
    Due to the limited information on the unknown cause(s) of Amyotrophic Lateral Sclerosis (ALS), the Agency for Toxic Substances and Disease Registry (ATSDR) established the National ALS Registry in 2010. The primary purpose of the ALS Registry is to e...
    File Type:
    Filetype[PDF - 79.63 KB]
  3. Prevalence of amyotrophic lateral sclerosis — United States, 2012–2013
    Personal Author:
    Mehta, Paul; Kaye, Wendy; Bryan, Leah; Larson, Theodore C.; Copeland, Timothy; Wu, Jennife; Muravov, Oleg; Horton, Kevin;
    Corporate Author:
    United States. Agency for Toxic Substances and Disease Registry.
    Published:
    August 5, 2016
    Series:
    MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries; v. 65, no. SS-8
    Description:
    Problem/Condition: Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, is a progressive and fatal neuromuscular disease for which no cure or viable treatment has been identified. ALS, like most noncommunicable diseases, is ...
    File Type:
    Filetype[PDF - 449.78 KB]
  4. National Amyotrophic Lateral Sclerosis (ALS) Registry – impact, challenges, and future directions
    Personal Author:
    Horton, D. Kevin; Mehta, Paul; Kasarskis, Edward J.; Tessaro, Ed; Iskander, John K.; Thorpe, Phoebe; Laird, Susan;
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication.; United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health Sciences. Environmental Health and Surveillance Branch.;
    Published:
    April 18, 2017
    Series:
    Public Health grand rounds ; 2017 April 18
    Description:
    Tuesday, April 18, 2017, at 1:00 p.m. ET : Amyotrophic Lateral Sclerosis (ALS), sometimes called Lou Gehrig’s disease, is a rapidly progressive, fatal neurological disease caused by degeneration of motor neurons in the brain and spinal cord. Resear...
    File Type:
    Filetype[PDF - 6.04 MB]
  5. ATSDR’s Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : August 13 – 14, 2014 summary report
    Corporate Author:
    United States. Agency for Toxic Substances and Disease Registry.
    Published:
    2014
    Description:
    This document has not been revised or edited to conform to agency standards. The findings and conclusions in this report are those of the meeting presenters and attendees and do not necessarily represent the views of the Agency for Toxic Substances a...
    File Type:
    Filetype[PDF - 3.59 MB]